As the dust settled around the implementation of the Affordable Care Act, private equity activity in health-care climbed to $6.7 billion in 2014, up from the $4.7 billion a year earlier.

While many predict 2015 will be another busy year for health-care investing, others say deal making is difficult not only because of high prices, but that the robust public market is luring companies to bypass private equity. Join Private Equity Analystâ€™s Amy Or Thursday, March 5 at 2 p.m. as she talks with industry experts about the challenges and opportunities for deal makers in the space.

Speakers:

Andrew Cavanna, Managing Director, Vestar Capital

Dean Mihas, Managing Director, GTCR

Jeremy Gelber, Partner, Pamplona Capital Management

Philip Pfrang, Partner, Deloitte & Touche LLP